Learning
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
From MMRGlobal FB page 3 minutes ago.
As we prepare to wrap up the year with the filing of MMRGlobal’s 2013 10-K (OTC: MMRF) I wanted to share an observation that demonstrates why MMR believes it is in the right place at the right time.
Based on the March 19th IPO of Castlight Health Systems (NYSE:CSLT), MMR is clearly in the right place at the right time. We believe that Healthcare.gov’s spending of more than $379 million helped created a marketplace environment catalyst that made it possible for a Health Information Technology company with $13 million in revenue to go public on the NYSE & trade at more than a 150 times multiple, or more than two billion dollars.
Ironically, Castlight and MMR both sell products and services that target consumers and employers. That’s why one of MMR’s management agendas in 2014 is to stabilize our market and thereby reward our shareholders when we enter into licensing and settlement agreements consistent with our business plan throughout the year. We think that based on current comparable’s in HIT we believe it is one of the most responsible agendas we can put forth.
Since MMR’s inception, we predicted that 2014 would be the year of transition in health care, and that consumers and employers would finally begin realizing the benefits in managed care by utilizing products and services like ours and Castlight’s to take advantage of the best in medicine at the lowest in cost. And what better time for MMR then the beginning of a transition of our nation’s entire health care system.
I also want to thank all who have continued to support our Company over the past several years in our efforts to sell and license our personal health record and other health information technology products & services.
Robert H. "Bob" Lorsch, CEO, MMRGlobal
www.mmrvideos.com
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010
Follow me on Twitter at BobLorschTweets
What it does mean is there are going to be a lot of companies between now & May 1st that end up doing a reverse split. I also believe it will be good for the OTC, they have been listening to the complaints and are doing something about it. Scams will still occur but this makes it harder on them. Live by the dilution, die by the dilution
On May 1 for its OTCQB market, OTC Markets will introduce a new minimum one-cent bid price requirement and will require the company's chief executive or chief financial officer to certify that its reporting obligations are current and that disclosures about shareholdings, officers and corporate profile are correct.
The bid requirement, in which stocks must have been quoted for at least 1 cent daily over a 30-day period or be dropped from the market, aims to ferret out companies that fall prey to dilutive stock fraud schemes and promotions, OTC Markets said.
US over-counter trading tightens reporting, other standards
NEW YORK, Wed Mar 26, 2014 4:15pm EDT
(Reuters) - OTC Markets, the operator of three U.S. over-the-counter equity markets, is rolling out tighter reporting standards and eligibility requirements for its venture-stage market to crack down on stock scams and bolster transparency, the company said on Wednesday.
On May 1 for its OTCQB market, OTC Markets will introduce a new minimum one-cent bid price requirement and will require the company's chief executive or chief financial officer to certify that its reporting obligations are current and that disclosures about shareholdings, officers and corporate profile are correct.
The bid requirement, in which stocks must have been quoted for at least 1 cent daily over a 30-day period or be dropped from the market, aims to ferret out companies that fall prey to dilutive stock fraud schemes and promotions, OTC Markets said.
OTC Markets also will charge a one-time $2,500 fee for new applicants and an annual $10,000 fee for companies trading on its markets.
Foreign companies that are listed on a qualified stock exchange and are current in their U.S. reporting obligations will be allowed to trade on OTCQB, OTC Markets' middle-tier marketplace. In the past, they traded on the lowest "pink" tier.
On Tuesday, the two most actively traded stocks on OTC Markets on Tuesday were French dairy products maker Danone SA and Swiss pharmaceuticals Roche Holding AG .
Trading volume on OTC Markets was 20.1 billion shares on Tuesday, about three times that of all U.S. stock exchanges and other trading venues. But the value traded, $1.4 billion, paled in comparison with the $263.4 billion executed on the other exchanges and venues, data from BATS Global Markets showed. (Reporting by Herbert Lash)
http://www.reuters.com/article/2014/03/26/otcmarkets-reforms-idUSL1N0MN13N20140326
US over-counter trading tightens reporting, other standards
NEW YORK, Wed Mar 26, 2014 4:15pm EDT
(Reuters) - OTC Markets, the operator of three U.S. over-the-counter equity markets, is rolling out tighter reporting standards and eligibility requirements for its venture-stage market to crack down on stock scams and bolster transparency, the company said on Wednesday.
On May 1 for its OTCQB market, OTC Markets will introduce a new minimum one-cent bid price requirement and will require the company's chief executive or chief financial officer to certify that its reporting obligations are current and that disclosures about shareholdings, officers and corporate profile are correct.
The bid requirement, in which stocks must have been quoted for at least 1 cent daily over a 30-day period or be dropped from the market, aims to ferret out companies that fall prey to dilutive stock fraud schemes and promotions, OTC Markets said.
OTC Markets also will charge a one-time $2,500 fee for new applicants and an annual $10,000 fee for companies trading on its markets.
Foreign companies that are listed on a qualified stock exchange and are current in their U.S. reporting obligations will be allowed to trade on OTCQB, OTC Markets' middle-tier marketplace. In the past, they traded on the lowest "pink" tier.
On Tuesday, the two most actively traded stocks on OTC Markets on Tuesday were French dairy products maker Danone SA and Swiss pharmaceuticals Roche Holding AG .
Trading volume on OTC Markets was 20.1 billion shares on Tuesday, about three times that of all U.S. stock exchanges and other trading venues. But the value traded, $1.4 billion, paled in comparison with the $263.4 billion executed on the other exchanges and venues, data from BATS Global Markets showed. (Reporting by Herbert Lash)
http://www.reuters.com/article/2014/03/26/otcmarkets-reforms-idUSL1N0MN13N20140326
US over-counter trading tightens reporting, other standards
NEW YORK, Wed Mar 26, 2014 4:15pm EDT
(Reuters) - OTC Markets, the operator of three U.S. over-the-counter equity markets, is rolling out tighter reporting standards and eligibility requirements for its venture-stage market to crack down on stock scams and bolster transparency, the company said on Wednesday.
On May 1 for its OTCQB market, OTC Markets will introduce a new minimum one-cent bid price requirement and will require the company's chief executive or chief financial officer to certify that its reporting obligations are current and that disclosures about shareholdings, officers and corporate profile are correct.
The bid requirement, in which stocks must have been quoted for at least 1 cent daily over a 30-day period or be dropped from the market, aims to ferret out companies that fall prey to dilutive stock fraud schemes and promotions, OTC Markets said.
OTC Markets also will charge a one-time $2,500 fee for new applicants and an annual $10,000 fee for companies trading on its markets.
Foreign companies that are listed on a qualified stock exchange and are current in their U.S. reporting obligations will be allowed to trade on OTCQB, OTC Markets' middle-tier marketplace. In the past, they traded on the lowest "pink" tier.
On Tuesday, the two most actively traded stocks on OTC Markets on Tuesday were French dairy products maker Danone SA and Swiss pharmaceuticals Roche Holding AG .
Trading volume on OTC Markets was 20.1 billion shares on Tuesday, about three times that of all U.S. stock exchanges and other trading venues. But the value traded, $1.4 billion, paled in comparison with the $263.4 billion executed on the other exchanges and venues, data from BATS Global Markets showed. (Reporting by Herbert Lash)
http://www.reuters.com/article/2014/03/26/otcmarkets-reforms-idUSL1N0MN13N20140326
US over-counter trading tightens reporting, other standards
NEW YORK, Wed Mar 26, 2014 4:15pm EDT
(Reuters) - OTC Markets, the operator of three U.S. over-the-counter equity markets, is rolling out tighter reporting standards and eligibility requirements for its venture-stage market to crack down on stock scams and bolster transparency, the company said on Wednesday.
On May 1 for its OTCQB market, OTC Markets will introduce a new minimum one-cent bid price requirement and will require the company's chief executive or chief financial officer to certify that its reporting obligations are current and that disclosures about shareholdings, officers and corporate profile are correct.
The bid requirement, in which stocks must have been quoted for at least 1 cent daily over a 30-day period or be dropped from the market, aims to ferret out companies that fall prey to dilutive stock fraud schemes and promotions, OTC Markets said.
OTC Markets also will charge a one-time $2,500 fee for new applicants and an annual $10,000 fee for companies trading on its markets.
Foreign companies that are listed on a qualified stock exchange and are current in their U.S. reporting obligations will be allowed to trade on OTCQB, OTC Markets' middle-tier marketplace. In the past, they traded on the lowest "pink" tier.
On Tuesday, the two most actively traded stocks on OTC Markets on Tuesday were French dairy products maker Danone SA and Swiss pharmaceuticals Roche Holding AG .
Trading volume on OTC Markets was 20.1 billion shares on Tuesday, about three times that of all U.S. stock exchanges and other trading venues. But the value traded, $1.4 billion, paled in comparison with the $263.4 billion executed on the other exchanges and venues, data from BATS Global Markets showed. (Reporting by Herbert Lash)
http://www.reuters.com/article/2014/03/26/otcmarkets-reforms-idUSL1N0MN13N20140326
US over-counter trading tightens reporting, other standards
NEW YORK, March 26 Wed Mar 26, 2014 4:15pm EDT
I would have to believe MMRGlobal, Inc. & the other companies on the OTC have already been notified regarding this. Bone
(Reuters) - OTC Markets, the operator of three U.S. over-the-counter equity markets, is rolling out tighter reporting standards and eligibility requirements for its venture-stage market to crack down on stock scams and bolster transparency, the company said on Wednesday.
On May 1 for its OTCQB market, OTC Markets will introduce a new minimum one-cent bid price requirement and will require the company's chief executive or chief financial officer to certify that its reporting obligations are current and that disclosures about shareholdings, officers and corporate profile are correct.
The bid requirement, in which stocks must have been quoted for at least 1 cent daily over a 30-day period or be dropped from the market, aims to ferret out companies that fall prey to dilutive stock fraud schemes and promotions, OTC Markets said.
OTC Markets also will charge a one-time $2,500 fee for new applicants and an annual $10,000 fee for companies trading on its markets.
Foreign companies that are listed on a qualified stock exchange and are current in their U.S. reporting obligations will be allowed to trade on OTCQB, OTC Markets' middle-tier marketplace. In the past, they traded on the lowest "pink" tier.
On Tuesday, the two most actively traded stocks on OTC Markets on Tuesday were French dairy products maker Danone SA and Swiss pharmaceuticals Roche Holding AG .
Trading volume on OTC Markets was 20.1 billion shares on Tuesday, about three times that of all U.S. stock exchanges and other trading venues. But the value traded, $1.4 billion, paled in comparison with the $263.4 billion executed on the other exchanges and venues, data from BATS Global Markets showed. (Reporting by Herbert Lash)
http://www.reuters.com/article/2014/03/26/otcmarkets-reforms-idUSL1N0MN13N20140326
MMRF Boarders, I have had several conversations with Bob Lorsch over the last couple years and feel strongly that he believes in this company, its concept & the patents it has secured & is in the process of securing. I also believe he is giving it 110% regardless whether we like how he is managing the company.
So if anyone here feels the SEC needs to be contacted, so be it. Please contact them but don't ask the rest of us to be doing your DD.
Contact the SEC and have the trading audited. Easy enough to do. it's what the SEC does every day
Los Angeles Regional Office
Michele Wein Layne, Regional Director
5670 Wilshire Boulevard, 11th Floor
Los Angeles, CA 90036-3648
323) 965-3998
e-mail: losangeles@sec.gov
Your comment regarding "desperation" is strictly your opinion.
It may seem like desperation to you, but if someone is selling... someone has to BUYING.... no one knows except the seller, his/her reasons except them, maybe they had an emergency & needed the money. You nor do I know.
BL told me 2 weeks ago it was not him selling nor was he diluting shares.
Let's see what additional announcements the company may have after the March 24th post on Facebook. I know I want & am ready to hear the news.
MMR Expands Patent Portfolio to Legal Records
"MMR received a Notice of Allowance from the U.S. Patent Office dated March 24, 2014 on U.S. Patent Application Serial No. 12/204,498 titled "METHOD AND SYSTEM FOR PROVIDING ONLINE RECORDS." The allowed application expands MMR's Health Information Technology Patent Portfolio to includes claims directed towards accessing and collecting legal records amongst other things. The Company plans to make additional announcements over the next several days.
Could someone please provide me a link or link to what Genta did & the cancers they were into?
Like I posted earlier I haven't watched this stock to closely but she is falling fast.
I thought this was supposed to be on the move this week with some demonstration? What ever happened with the Navy deal that was supposedly being worked on?
Please excuse Johnny-Come-Lately but I have little in this but always thought it had potential. So I don't follow this board closely.
From MMRGlobal's FB page a few seconds ago. Check it out, I can not get the image right.
https://www.facebook.com/MMRGlobal/posts/10152281417879002?notif_t=notify_me
Coming Soon!
The new MyMedicalRecords sign up pages. Watch for us everywhere starting next week. Watch Fran and support Cancer Schmancer http://med1.simplymint.com/
Nice find guy, have a good weekend.
T1, you're smarter than I but I'm glad to see someone (doesn't surprise me its you) pickup on that post.
Its coming T, we need to watch that vote on the 24th & 25th. I'm going to have to go buy me a camera for my puter. I'll share 1 more thing that I believe & have been speculating on.
CVS is getting out of the TOBACCO business by this October or November. No company gives up 2 BILLION a year in sales with out a plan to replace it.
So I believe they will move fast & strong into the medical field treating the consumer on many more levels than they are currently doing, general doctors, nurse practioners etc. My local CVS is going to have to grow a larger facility.
I made a post out hear recently that if you all didn't find me foolish regarding my comments on the PPS & the share selloff you all surely must be starting to at least suspect that now. lol...
MMRF Boyardee's, Stay Safe!
Proposed patient-centered telemedicine policy raises licensing questions
By Andis Robeznieks | Posted: March 20, 2014 - 3:45 pm ET
Tags: Hospitals, Information Technology, Insurance, Managed Care, Mayo Clinic, Medicaid, Physicians, Telemedicine
The Federation of State Medical Boards will vote next month on a new telemedicine policy (PDF) that codifies that medical care takes place where a patient, not a provider, is located. It also states that whether a physician and patient have a virtual or a face-to-face encounter, there should be no differences in standards of care.
The proposal carries implications for where doctors practicing telemedicine need to be licensed. “The practice of medicine occurs where the patient is located at the time telemedicine technologies are used,” the proposed policy states. “Physicians who treat or prescribe through online service sites are practicing medicine, and must possess appropriate licensure in all jurisdictions where patients receive care.”
Lisa Robin, FSMB chief advocacy officer, said the telemedicine policy actually grew out of an effort to simplify the licensing process for physicians seeking licenses in multiple states (PDF).
But the policy's stand on state license requirements may serve as a barrier, rather than as an aid to telehealth technology expansion, one expert contended.
Dr. Bart Demaerschalk, professor of neurology and director of telestroke and teleneurology at the Mayo Clinic in Phoenix, said he appreciated the proposed policy's directives to put patient welfare first, adhere to the highest standards of care, protect patients' privacy and securely store their information. But he lamented that the policy “may lack innovative thought” with its insistence that telemedicine doctors be licensed in every state where their patients are located.
While this is the Mayo Clinic's policy, he explained, it has been an administrative barrier to its program's growth. The clinic currently provides some 3,000 neurology consultations annually to 36 hospitals in 10 states.
The three biggest obstacles to telemedicine's expansion are administrative burdens and time required for state licensing and hospital credentialing; reimbursement; and the cost of technology, Demaerschalk said.
“The most stubborn of all has been the licensing,” he added.
Telemedicine barriers could add up to higher costs and poorer outcomes for patients, Demaerschalk said. A recent Mayo Clinic study appearing in the American Journal of Managed Care found that, compared to a patient in a rural community hospital, patients in a telestroke network incurred costs that were $1,436 lower.
Demaerschalk suggests the development of a national or multi-state license for telemedicine, or reversing the decision that the medicine is practiced in the patient's physical location.
According to the National Conference of State Legislatures, 43 states and the District of Columbia provide some form of Medicaid reimbursement for primary-care telehealth services, while 19 states and the District of Columbia now require private insurance plans to reimburse providers for telehealth primary-care services. Arizona will join this list in January 2015.
The proposed policy, which will be voted on during the FSMB's annual meeting April 24-25 in Denver, will serve as a model for other state boards to follow and as a guidepost for state legislators and regulators to develop their own telemedicine policies.
Joshua Ewing, an NCSL health policy specialist, said telemedicine is generating significant activity in state capitols.
“Many states are turning to telehealth as a way to address workforce challenges—particularly in rural and underserved areas,” Ewing said. “I think many states also feel that telehealth is here, and here to stay. Therefore, they want to make sure they are in front of the issue with proper regulations that ensure patients receive safe, high-quality healthcare that is comparable to that which they would receive in a normal face-to-face interaction with a doctor.”
http://www.modernhealthcare.com/article/20140320/NEWS/303209952?AllowView=VDl3UXk1TzZDUFNCbkJiYkY0M3hlMENyajBVZEQrUT0=&utm_source=link-20140320-NEWS-303209952&utm_medium=email&utm_campaign=hits&utm_name=bottom
2014 Health Privacy Summit, The 4th International Summit on the Future of Health Privacy. Controlling Your Personal Health Information: Now Is the Time
http://org2.salsalabs.com/o/6402/p/salsa/event/common/public/?event_KEY=69793
Larry Page of Google Wants Anonymous Medical Records Available for All Researchers To Use, But What Would Be the Cost? Insurer Subsidiaries and Others are Already In the Game As Data Sellers To Provide Such..
http://ducknetweb.blogspot.com/2014/03/larry-page-of-google-wants-anonymous.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+blogspot%2FPHZF+%28The+Medical+Quack%29
FE911, I'm not arguing with you & lord knows I hope you're right but do you have anything to support this comment you made?
These other billion $$$ companies have decided to be with MMR instead of defending what they previously were challenging.
I initially posted this last night at 1:00am CST.
I've been sitting here this evening & thinking about the week, the selling off of the stock.
1st those of you who know me know I have always been long & strong with this company though like many I've been shaken so I've been thinking.
Here is what my thoughts have come to.... We've had a lot of hype & expectations the last couple of weeks & things happened as I thought I just didn't here about any $$$ that went with it.
However, and I've said it before the silence regarding the points of the agreements have been deafening.... we (MMRF) still have 2 signed agreements with 2 companies who's sales total almost 100 BILLION dollars a year and both are global organizations.
So other than the sell off by investors (because I talked to BL & he didn't know where the selling was coming from) bringing the stock back down to the $0.03's I'm no worst off than I was at the close of last Friday. If what I have written up to this point hasn't sounded stupid to you all this paragraph surely must.
Tbone is over the initial shock & have decided to stay in the ball game with MMRF. I'll wait & see what the agreements & others (I'm assuming) might bring.
GLTEveryone & above all Stay Safe!
Robert H. "Bob" Lorsch, CEO, MMRGlobal
4401 Wilshire Blvd., 2nd Floor,
Los Angeles, CA 90010,
Tel. 310-476-7002, Fax 206-374-6136
www.mmrglobal.com
www.mymedicalrecords.com
Put a call into him, he'll talk to you. And if he's not in he'll return your call.
MMRGlobal CEO Robert H. Lorsch to Be Interviewed by Michael Yorba on Clear Channel Business Talk Radio.
Interview Airs March 12th at 1:30pm CDT on The Traders Network Radio Show, DFW 1190AM KFXR
http://ih.advfn.com/p.php?pid=nmona&article=61407359&symbol=MMRF
The live interview details are as follows:
Live Stream via iHeart Radio:
http://www.iheart.com/live/4276/?autoplay=true
Cerner settled dispute with $106.2 million payment
March 10 - By MARK DAVIS - The Kansas City Star
Cerner Corp. settled its dispute with a North Dakota hospital by paying $106.2 million, the health information technology company said.
Its payment, the result of an arbitration ruling, ended Cerner’s battle over a patient accounting product that Trinity Medical Center in Minot, N.D., had purchased in 2008.
“As of December 28, 2013, this matter has been resolved and paid,” Cerner said in its recent annual filing with the Securities and Exchange Commission.
In April 2012, Trinity told Cerner it was moving to another system, “alleging that the patient accounting solution purchased in 2008 was defective and did not deliver the promised benefits,” the filing said.
In December, Cerner said that the two sides had agreed to arbitrate the dispute and that an interim ruling would cut into Cerner’s fourth-quarter earnings. The arbitration ruling also allowed Cerner to collect some payments due from the hospital, Cerner’s annual filing said.
Financially, the ruling’s impact would reduce earnings 18 or 19 cents a share, Cerner said in December.
The North Kansas City-based company’s earnings announcement said the charge cut 19 cents from fourth-quarter earnings and amounted to $68.078 million after being reduced by a tax benefit $38.1 million.
In an earlier filing, Cerner had said Trinity claimed damages of $240 million and that Cerner’s expert witness had estimated the hospital’s “total damages, assuming any liability by Cerner, of up to $4 million.”
Heading into the arbitration, Cerner had said that 147 hospitals and 735 clinics were using its patient accounting product.
Read more here: http://www.kansascity.com/2014/03/10/4878599/cerner-settled-dispute-with-1062.html#storylink=cpy
http://www.kansascity.com/2014/03/10/4878599/cerner-settled-dispute-with-1062.html
Allscripts EHR ranked large hospitals' favorite by Black Book
By Joseph Conn, 4 Hours Ago
Chicago-based Allscripts Healthcare Solutions scored highest in customer satisfaction for electronic health-record systems used by larger hospitals and academic medical centers, according to the latest rankings from healthcare information technology industry analyst Black Book Market Research.
It was the first time in four years that Allscripts topped the big hospital list compiled by Tampa-based Black Book from results of an online survey of hospital IT leaders. Results this year also marked the first time Epic Systems did not, said Doug Brown, Black Book's managing partner.
Cerner, McKesson and Quadramed rounded out the top five vendors among large hospital customers. All five of the top-ranked vendors each placed first in at least two of the 18 categories in which Black Book questioned its customers and measured results. Allscripts led in seven of those categories, Epic in four. The difference between them in the composite mean scores across all 18 categories gave Allscripts the edge—albeit at two decimal places—9.44 to 9.41.
“It was the big medial centers that gave Allscripts their top scores,” Brown said. “All of the margins were close,” with faltering by other top vendors in some customer satisfaction categories that allowed Allscripts to move up, he said.
According to Black Book, 1,985 hospital IT professionals from 163 facilities—including group practices affiliated with the academic medical centers—participated in this part of the Web-based survey, conducted from September through December last year.
For the fourth consecutive year, Cerner gained top honors in the Black Book ratings for community hospitals from 100 to 299 beds, followed by Siemens, McKesson, Epic and Allscripts.
CPSI (Computer Programs and Systems Inc.), also for four years running, topped the Black Book list of vendors rated by customers at small, rural and critical-access hospitals, all with fewer than 100 beds. Cerner ranked No. 2 in this category, followed by Healthland, HMS (Health Management Systems) and RazorInsights.
http://www.modernhealthcare.com/article/20140311/BLOG/303119996?AllowView=VDl3UXk1TzZDL1dCa0IvREE0M3hlMENvamtVZEErQT0=&utm_source=link-20140311-BLOG-303119996&utm_medium=email&utm_campaign=hits&utm_name=bottom
Video News: Cerner President Zane Burke on the next wave in health IT
In an interview at the recent HIMSS show in Orlando, Fla., Cerner President Zane Burke explains how the company is positioning itself for new business now that most U.S. hospitals and physicians have already chosen an EHR vendor. See all of our HIMSS coverage here. Click link to see video....
http://www.modernhealthcare.com/article/20140311/VIDEO/140319997?AllowView=VDl3UXk1TzZDL1dCaEJySUFlM3Rla2VwakUwZEErOWE=&utm_source=link-20140311-VIDEO-140319997&utm_medium=email&utm_campaign=hits&utm_name=bottom#
When BL sold out to ATT, did the other share holders not have an opportunity to sell their shares as well at the time?
Webinar - Patient Engagement: Improving Care and Reducing Costs
Wednesday, March 12th, 2014 at 12:15pm ET
When attesting to Stage 2 Meaningful Use, patient engagement is more than important—it’s mandatory. But what does it mean to truly engage patients in their own care? Yes, an online patient portal is a very important aspect, but genuine patient engagement is more than that.
In this free webinar, learn how you can use patient engagement services your patients demand, your bottom line needs and Meaningful Use Stage 2 requires. athenahealth’s Matt Hoenigsberg will discuss the steps to achieving a true patient engagement strategy. You’ll learn how to:
Define your vision for patient engagement
Create a culture of engagement
Employ the right technology and services
Empower patients to become collaborators in care
Chart progress and along the way
Register today to learn more.
http://info.athenahealth.com/patient-engagement.html?partnerref=701G0000000tIQIIA2&status=responded
Patients Need Some Hand Holding with Secure Messaging
Secure electronic communication has significant potential to improve patient engagement, but in order to fully realize its potential, health care organizations must provide users with sufficient education and also provide a sense of confidentiality, according to a new study from Veterans Affairs researchers.
The researchers reported barriers to satisfied use of the secure messaging tool included veterans' discomfort with learning that members of their primary care teams other than the intended provider had access to their messages, care teams' discouraging the veterans from sending personal non-health related information, and refusal by care team staff to use the portal, instead reverting to telephone calls.
"Veterans perceive secure messaging in the My HealtheVet patient portal as a useful tool for communicating with health care teams," the researchers concluded in the study, published in the Journal of Medical Internet Research. "However, to maximize sustained utilization of Secure Messaging, marketing, education, skill building, and system modifications are needed. Data from this study can inform a large-scale quantitative assessment of Secure Messaging users’ experiences in a representative sample to validate qualitative findings."
The researchers used a combination of face-to-face questioning, telephone interviews, and review of secure transmitted messages sent by 33 subjects to gauge the utility of the portal. Eighty-two percent of the veterans were satisfied with the portal at the beginning of the study, and that number rose to 97 percent during the follow-up interviews.
http://www.healthdatamanagement.com/news/VA-study-patient-secure-messaging-47399-1.html?utm_campaign=daily-mar%2011%202014&utm_medium=email&utm_source=newsletter
Well I'm happy over the WAG & CERN news but until some $$$ are disclosed if there are some I don't see this moving. Only 25k moved in the 1st hour & now we're @ 418k with a POS @ $0.0449. Down from Friday's close.
I was sure looking/hoping for more.
Eyes Wide Shut: Meaningful Use Stage 2 Incentive Program Hardships
In my January update on Meaningful Use Stage 2 readiness, I painted a dismal picture of a large IDN’s journey towards attestation, and expressed concern for patient safety resulting from the rush to implement and adopt what equates to, at best, beta-release health IT. Given the resounding cries for help from the healthcare provider community, including this February 2014 letter to HHS Secretary Kathleen Sebelius, I know my experience isn’t unique. So, when rumors ran rampant at HIMSS 2014 that CMS and the ONC would make a Meaningful Use announcement, I was hopeful that relief may be in sight.
Like AHA , I was disappointed in CMS Administrator Marilyn Tavenner’s announcement. The new Stage 2 hardship exemptions will now include an explicit criteria for “difficulty implementing 2014-certified EHR technology” – a claim which will be evaluated on a case-by-case basis, and may result in a delay of the penalty phase of the Stage 2 mandate. But it does nothing to extend the incentive phase of Stage 2 – without which, many healthcare providers would not have budgeted for participation in the program, at all, including the IDN profiled in this series. So how does this help providers like mine?
Quick update on my IDN’s progress towards Stage 2 attestation, with $MM in target incentive dollars at stake. We must meet ALL measures; there is no opportunity to defer one. The Transition of Care (both populating it appropriately, and transmitting it via Direct) is the primary point of concern.
The hospital EHR is ready to generate and transmit both Inpatient Summary and Transition of Care C-CDAs. The workflow to populate the ToC required data elements adds more than 4 minutes to the depart process, which will cause operational impacts. None of the ambulatory providers in the IDN have Direct, yet; there is no one available to receive an electronic ToC. Skilled resources to implement Direct with the EHR upgrades are not available until 6-12 weeks after each upgrade is complete.
None of the 3 remaining in-scope ambulatory EHRs have successfully completed their 2014 software upgrades. 2 of the 3 haven’t started their upgrades. 1 has not provided a DATE for the upgrade.
None of the ambulatory EHRs comes with a Clinical Summary C-CDA configured out-of-the-box. 1 creates a provider-facing Transition of Care C-CDA, but does not produce the patient-facing Clinical Summary. (How did this product become CEHRT for 2014 measures?) Once the C-CDA is configured, each EHR requires its own systems integrator to develop the interface to send the clinical document to an external system.
Consultant costs continue to mount, as each new wrinkle arises. And with each wrinkle, the ability to meet the incentive program deadlines, safely, diminishes.
Playing devil’s advocate, I’d say the IDN should have negotiated its vendor contracts to include penalty clauses sufficient to cover the losses of a missed incentive program deadline – or, worst case scenario, to cover the cost of a rip-and-replace should the EHR vendor not acquire certification, or have certification revoked. The terms and conditions should have covered every nuance of the functionality required for Stage 2 measures.
But wait, CMS is still clarifying its Stage 2 measures via FAQs. Can’t expect a vendor to build software to specifications that weren’t explicitly defined, or to sign a contract that requires adherence to unknown criteria.
So, what COULD CMS and the ONC do about it? How about finalizing your requirements BEFORE issuing measures and certification criteria? Since that ship’s already sailed, change the CEHRT certification process.
1. Require vendors to submit heuristics on both initial implementation and upgrades, indicating the typical timeline from kick-off to go-live, number of internal and external resources (i.e., third-party systems integrators), and cost.
2. Require vendors to submit customer-base profile detailing known customers planning to implement and/or upgrade within calendar year. AND require implementation/upgrade planning to incorporate 3 months of QA time post-implementation/upgrade, prior to go-live with real patients.
3. Require vendors to submit human resource strategy, and hiring and training program explicitly defined to support the customer-base profile submitted, with the typical timeframes and project resource/cost profiles submitted.
4. Require vendor products to be self-contained to achieve certification – meaning, no additional third-party purchase (software or professional services) would be necessary in order to implement and/or upgrade to the certified version and have all CMS-required functionality.
5. Require vendor products to prove the CEHRT-baseline functionality is available as configurable OOTB, not only available via customization. SHOW ME THE C-CDA, with all required data elements populated via workflow in the UI, not via some developer on the back-end in a carefully-orchestrated test patient demo script.
6. Require vendor products adhere to an SLA for max number of clicks required to execute the task. It is not Meaningful Use if it’s prohibitively challenging to access and use in a clinical setting.
Finally, CMS could redefine the incentive program parameters to include scenarios like mine. Despite the heroic efforts being made across the enterprise, this IDN is not likely to make it, with the fault squarely on the CEHRT vendors’ inability to deliver fully-functional products in a timely manner with skilled resources available to support the installation, configuration, and deployment. Morale will significantly decline, next year’s budget will be short the $MM that was slated for further health IT improvements, and the likelihood that it will continue with Stage 3 becomes negligible. Vendor lawsuits may ensue, and the incentive dollar targets may be recouped, but the cost incurred by the organization, its clinicians, and its patients is irrecoverable.
Consider applying the hardship exemption deadline extension to the incentive program participants.
http://www.emrandhipaa.com/mandi/2014/03/05/eyes-wide-shut-meaningful-use-stage-2-incentive-program-hardships/
FJ, did you find the phr on their website? I looked this morning & found nothing. Though we really do not know the final deals of WAG buying into MMRF patent family, I have already found 1 down side.
I'm going to have to move mine & my mothers prescriptions from CVS to WAG. Both are located about 4 or 5 blocks from us but a pain in the A$$ anyway.
Just out from Medical Quack regarding Walgreens Lawsuits
Walgreens and MyMedicalRecords Reach Settlement Agreement Related to Patent Infringements
This is one of several patent infringements suits filed by MMRGlobal and if you read here often enough I have covered several of them to include Allscripts for one. This is an interesting settlement as part of the agreement also states that the subsidiary of Walgreens, Drugstore.com will also be selling the PHR from MMRGlobal, MyMedicalRecords.com on their website. Here’s the original post from my archives with additional details regarding the patents that were in question.
MMRglobal (MyMedicalRecords.Com) Files Complaint In California Against Walgreen For Technology Patent Violations
Just a few days ago I also had a post with Walgreens filing patent infringements against CVS and Rite-Aid.
Walgreens Suing CVS, Rite Aid, Wants License and IP Damage Reimbursement, Patent Violations, Software Used For Refilling Prescriptions Via Mobile Phone Scanners…Not Getting Enough Data to Sell?
There have been a couple other patent infringement cases settled such as Interbit but this appears to be the largest so far. A couple years ago I spoke with Bob Lorsch about the patent violations before many of the larger cases had been filed. Their original PHR patents filed go back a number of years and there are some additional pending applications that I assume relate to the original technologies that were covered.
MMRglobal Patent Portfolio, Bob Lorsch, CEO Answers Questions Relative to Patented Technologies
The dollar amount of the settlement was not stated as far as what Walgreens paid for the license purchased. Below is the press release from today. Read more... BD
http://ducknetweb.blogspot.com/2014/03/walgreens-and-mymedicalrecords-reach.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+blogspot%2FPHZF+%28The+Medical+Quack%29
Just out from Medical Quack
Walgreens and MyMedicalRecords Reach Settlement Agreement Related to Patent Infringements
This is one of several patent infringements suits filed by MMRGlobal and if you read here often enough I have covered several of them to include Allscripts for one. This is an interesting settlement as part of the agreement also states that the subsidiary of Walgreens, Drugstore.com will also be selling the PHR from MMRGlobal, MyMedicalRecords.com on their website. Here’s the original post from my archives with additional details regarding the patents that were in question.
MMRglobal (MyMedicalRecords.Com) Files Complaint In California Against Walgreen For Technology Patent Violations
Just a few days ago I also had a post with Walgreens filing patent infringements against CVS and Rite-Aid.
Walgreens Suing CVS, Rite Aid, Wants License and IP Damage Reimbursement, Patent Violations, Software Used For Refilling Prescriptions Via Mobile Phone Scanners…Not Getting Enough Data to Sell?
There have been a couple other patent infringement cases settled such as Interbit but this appears to be the largest so far. A couple years ago I spoke with Bob Lorsch about the patent violations before many of the larger cases had been filed. Their original PHR patents filed go back a number of years and there are some additional pending applications that I assume relate to the original technologies that were covered.
MMRglobal Patent Portfolio, Bob Lorsch, CEO Answers Questions Relative to Patented Technologies
The dollar amount of the settlement was not stated as far as what Walgreens paid for the license purchased. Below is the press release from today. Read more... BD
http://ducknetweb.blogspot.com/2014/03/walgreens-and-mymedicalrecords-reach.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+blogspot%2FPHZF+%28The+Medical+Quack%29
From Yahoo Fiancé About 2 Hours Ago.
Walgreens and MyMedicalRecords Reach Settlement Agreement
LOS ANGELES, CA and DEERFIELD, IL--(Marketwired - Mar 6, 2014) - MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"), and Walgreen Co. (NYSE: WAG) (NASDAQ: WAG) ("Walgreens") announced today that they have entered into a Settlement and Licensing Agreement (the "Agreement") to resolve two patent infringement lawsuits brought by MMR. Pursuant to the terms of the Agreement, Walgreens purchased a Non-Exclusive License to the MMR family of patents. The settlement arises from litigation involving MMR's U.S. Patent No. 8,301,466 and U.S. Patent No. 8,498,883. MMR's patent portfolio also includes U.S. Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883; 8,626,532 and 8,645,161 as well as numerous pending applications. Pursuant to the terms of the Agreement, Walgreens has also agreed to sell MMR's MyMedicalRecords Personal Health Record (the "MMR-PHR") on drugstore.com. The remaining terms of the Agreement are confidential.
I do not know what MMRF released but the news I read was posted on Yahoo Fiance
6toes, no problem, we all new what you meant. I can speak for many hear... Welcome to the board, glad to have you.
From Yahoo Fiancé 1 hour ago.
Walgreens and MyMedicalRecords Reach Settlement Agreement
LOS ANGELES, CA and DEERFIELD, IL--(Marketwired - Mar 6, 2014) - MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"), and Walgreen Co. (NYSE: WAG) (NASDAQ: WAG) ("Walgreens") announced today that they have entered into a Settlement and Licensing Agreement (the "Agreement") to resolve two patent infringement lawsuits brought by MMR. Pursuant to the terms of the Agreement, Walgreens purchased a Non-Exclusive License to the MMR family of patents. The settlement arises from litigation involving MMR's U.S. Patent No. 8,301,466 and U.S. Patent No. 8,498,883. MMR's patent portfolio also includes U.S. Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883; 8,626,532 and 8,645,161 as well as numerous pending applications. Pursuant to the terms of the Agreement, Walgreens has also agreed to sell MMR's MyMedicalRecords Personal Health Record (the "MMR-PHR") on drugstore.com. The remaining terms of the Agreement are confidential.
Yo bro, why hasn't this become a sticky?
Oh yes GoPack... that look's like a sticky to me regarding the settlement.
Fire It Up!
Morning yeababy39, we got our eye's both of them on the BALL. We've been here to long not 2. Have a good day buddy.